Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $21.4800 (-2.63%) ($20.0400 - $21.9400) on Fri. Jun. 24, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.42% (three month average) | RSI | 63 | Latest Price | $21.4800(-2.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) IBB(51%) ARKG(50%) IWO(47%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -2.21% in a week (0% probabilities). VIXM(-17%) TLT(-13%) UUP(-10%) UNG(-3%) IPO(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.21% (StdDev 4.42%) | Hourly BBV | 0 () | Intraday Trend | 3.5% | | | |
|
5 Day Moving Average | $21.62(-0.65%) | 10 Day Moving Average | $20.87(2.92%) | 20 Day Moving Average | $20.07(7.03%) | To recent high | -6% | To recent low | 41.9% | Market Cap | $1.596b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |